Cytosorbents Accounts Payable vs Cash Analysis

CTSO Stock  USD 0.89  0.01  1.14%   
Cytosorbents Crp financial indicator trend analysis is way more than just evaluating Cytosorbents Crp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cytosorbents Crp is a good investment. Please check the relationship between Cytosorbents Crp Accounts Payable and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Accounts Payable vs Cash

Accounts Payable vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cytosorbents Crp Accounts Payable account and Cash. At this time, the significance of the direction appears to have weak relationship.
The correlation between Cytosorbents Crp's Accounts Payable and Cash is 0.38. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of Cytosorbents Crp, assuming nothing else is changed. The correlation between historical values of Cytosorbents Crp's Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Cytosorbents Crp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., Cytosorbents Crp's Accounts Payable and Cash go up and down completely randomly.

Correlation Coefficient

0.38
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Cytosorbents Crp obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cytosorbents Crp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash

Cash refers to the most liquid asset of Cytosorbents Crp, which is listed under current asset account on Cytosorbents Crp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Cytosorbents Crp customers. The amounts must be unrestricted with restricted cash listed in a different Cytosorbents Crp account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Cytosorbents Crp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cytosorbents Crp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.At this time, Cytosorbents Crp's Selling General Administrative is very stable compared to the past year. As of the 13th of December 2024, Issuance Of Capital Stock is likely to grow to about 17.5 M, while Tax Provision is likely to drop (854.4 K).
 2021 2022 2023 2024 (projected)
Other Operating Expenses62.9M60.9M67.6M70.9M
Total Revenue40.1M29.4M36.3M38.2M

Cytosorbents Crp fundamental ratios Correlations

0.550.83-0.68-0.780.89-0.360.860.620.680.920.940.930.70.760.890.360.87-0.350.690.630.820.890.940.890.77
0.550.840.2-0.860.17-0.420.830.860.830.270.760.270.830.840.170.710.66-0.40.810.340.560.820.780.220.79
0.830.84-0.25-0.930.56-0.40.940.840.820.630.90.610.820.860.560.580.82-0.380.920.490.620.960.920.60.84
-0.680.2-0.250.17-0.930.16-0.310.050.03-0.89-0.45-0.860.0-0.07-0.930.26-0.470.17-0.07-0.55-0.45-0.33-0.43-0.82-0.15
-0.78-0.86-0.930.17-0.480.3-0.96-0.84-0.83-0.56-0.86-0.55-0.83-0.86-0.48-0.63-0.880.28-0.82-0.47-0.69-0.92-0.89-0.49-0.78
0.890.170.56-0.93-0.48-0.290.610.290.280.990.730.960.310.381.00.030.71-0.290.380.690.670.640.730.90.45
-0.36-0.42-0.40.160.3-0.29-0.49-0.03-0.23-0.33-0.45-0.41-0.24-0.27-0.30.23-0.361.0-0.35-0.36-0.26-0.42-0.44-0.2-0.26
0.860.830.94-0.31-0.960.61-0.490.770.780.680.910.680.780.830.620.510.89-0.480.820.550.720.950.940.580.78
0.620.860.840.05-0.840.29-0.030.770.820.360.730.290.820.840.280.930.66-0.010.810.350.60.810.780.370.8
0.680.830.820.03-0.830.28-0.230.780.820.360.770.431.00.990.280.670.66-0.210.840.170.610.830.770.460.92
0.920.270.63-0.89-0.560.99-0.330.680.360.360.790.970.390.460.990.110.79-0.330.440.710.730.70.790.910.51
0.940.760.9-0.45-0.860.73-0.450.910.730.770.790.80.790.840.730.490.89-0.440.740.630.850.930.970.760.85
0.930.270.61-0.86-0.550.96-0.410.680.290.430.970.80.460.520.960.020.78-0.410.430.630.740.70.780.920.56
0.70.830.820.0-0.830.31-0.240.780.821.00.390.790.461.00.30.680.68-0.210.810.190.660.830.790.490.93
0.760.840.86-0.07-0.860.38-0.270.830.840.990.460.840.521.00.380.670.73-0.250.830.260.70.870.840.540.94
0.890.170.56-0.93-0.481.0-0.30.620.280.280.990.730.960.30.380.020.71-0.30.380.680.660.640.720.90.44
0.360.710.580.26-0.630.030.230.510.930.670.110.490.020.680.670.020.430.250.580.180.480.560.530.140.63
0.870.660.82-0.47-0.880.71-0.360.890.660.660.790.890.780.680.730.710.43-0.340.630.590.820.850.890.70.7
-0.35-0.4-0.380.170.28-0.291.0-0.48-0.01-0.21-0.33-0.44-0.41-0.21-0.25-0.30.25-0.34-0.32-0.36-0.25-0.4-0.42-0.19-0.24
0.690.810.92-0.07-0.820.38-0.350.820.810.840.440.740.430.810.830.380.580.63-0.320.410.40.890.810.460.82
0.630.340.49-0.55-0.470.69-0.360.550.350.170.710.630.630.190.260.680.180.59-0.360.410.580.630.680.460.26
0.820.560.62-0.45-0.690.67-0.260.720.60.610.730.850.740.660.70.660.480.82-0.250.40.580.750.820.650.62
0.890.820.96-0.33-0.920.64-0.420.950.810.830.70.930.70.830.870.640.560.85-0.40.890.630.750.980.630.82
0.940.780.92-0.43-0.890.73-0.440.940.780.770.790.970.780.790.840.720.530.89-0.420.810.680.820.980.710.81
0.890.220.6-0.82-0.490.9-0.20.580.370.460.910.760.920.490.540.90.140.7-0.190.460.460.650.630.710.66
0.770.790.84-0.15-0.780.45-0.260.780.80.920.510.850.560.930.940.440.630.7-0.240.820.260.620.820.810.66
Click cells to compare fundamentals

Cytosorbents Crp Account Relationship Matchups

Cytosorbents Crp fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets27.4M90.0M89.5M63.2M53.3M55.9M
Short Long Term Debt Total16.1M1.0M13.8M18.3M18.3M19.2M
Total Current Liabilities9.9M10.2M13.7M9.7M14.5M15.3M
Net Debt3.9M(70.4M)(38.3M)(3.9M)4.2M4.4M
Retained Earnings(188.8M)(196.6M)(221.2M)(254.0M)(282.5M)(268.4M)
Cash12.2M71.4M52.1M22.1M14.1M13.2M
Common Stock Total Equity32.6K43.2K43.5K43.6K39.3K51.6K
Common Stock Shares Outstanding32.3M38.8M43.4M43.6M44.7M46.9M
Liabilities And Stockholders Equity27.4M90.0M89.5M63.2M53.3M55.9M
Total Liab24.0M10.7M26.9M27.9M30.0M31.5M
Property Plant And Equipment Gross3.0M3.1M18.6M23.3M25.2M26.4M
Total Current Assets20.9M82.5M64.3M33.8M25.7M17.6M
Accumulated Other Comprehensive Income526.0K(1.7M)525.6K2.3M529.3K555.8K
Other Current Liab5.6M7.0M9.5M7.9M6.4M6.7M
Total Stockholder Equity3.4M79.2M62.6M35.4M23.3M12.9M
Property Plant And Equipment Net3.0M3.1M18.6M23.3M22.1M23.2M
Non Current Assets Total6.5M7.5M25.2M29.5M27.6M28.9M
Cash And Short Term Investments12.2M71.4M52.1M22.1M14.1M14.1M
Non Current Liabilities Total14.0M582K13.3M18.1M15.4M16.2M
Other Stockholder Equity191.6M277.5M283.2M287.0M305.2M160.4M
Common Stock32.6K43.2K43.5K43.6K54.2K53.5K
Accounts Payable2.0M1.8M2.8M1.7M3.8M4.0M
Non Currrent Assets Other3.5M4.3M1.9M1.7M1.5M1.2M
Other Current Assets2.1M3.2M2.9M5.0M1.8M1.2M
Good Will1.8M2.6M3.4M4.2M4.9M5.1M
Intangible Assets3.4M4.2M4.7M4.4M3.9M4.1M
Other Assets123.5K5.4M6.6M1.7M2.0M1.1M
Property Plant Equipment3.0M2.1M18.6M10.7M12.4M13.0M
Long Term Debt6.0M9.3M13.4M5M2.5M3.8M
Net Receivables4.5M5.2M4.5M5.7M6.1M6.4M
Retained Earnings Total Equity(188.8M)(196.6M)(221.2M)(254.0M)(228.6M)(217.2M)
Inventory2.1M2.7M4.8M3.5M3.7M1.9M
Short Term Debt2.1M447.5K570.6K108.9K2.9M3.0M
Net Tangible Assets56.6K79.2M62.6M35.4M40.7M23.3M
Capital Surpluse191.6M277.5M283.2M287.0M330.1M215.6M
Short Long Term Debt4M666.7K1.7M2.5M2.9M1.8M

Pair Trading with Cytosorbents Crp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cytosorbents Stock

  0.68CI Cigna CorpPairCorr

Moving against Cytosorbents Stock

  0.82MD Mednax IncPairCorr
  0.81ECOR Electrocore LLCPairCorr
  0.72VREX Varex Imaging CorpPairCorr
  0.59LH LaboratoryPairCorr
  0.58DXCM DexCom IncPairCorr
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
0.72
Quarterly Revenue Growth
0.066
Return On Assets
(0.28)
Return On Equity
(1.19)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.